James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 58,600 shares at $16.21 ($950K) on 2016-08-16, disclosed to the SEC on 2016-08-18.
Open-market purchase of $950k RETA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |